Oya Yavuz
No más puestos en curso
Perfil
Oya Yavuz worked as Vice President of Investor Relations at Wolters Kluwer NV and as VP of Corporate Communications and Investor Relations at Crucell NV.
Antiguos cargos conocidos de Oya Yavuz.
| Empresas | Cargo | Fin |
|---|---|---|
| WOLTERS KLUWER N.V. | Contacto de Relaciones con Inversores | 01/06/2007 |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Contacto de Relaciones con Inversores | - |
Experiencias
Funciones ocupadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| WOLTERS KLUWER N.V. | Technology Services |
| Empresas privadas | 1 |
|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
- Bolsa de valores
- Insiders
- Oya Yavuz
